Prior studies have implicated hyperactive mTOR signaling as a key driver of tumorigenic transformation in CRC via its potent activation of downstream effector proteins, p70S6K and 4EBP1 [41, 43]. The gene discussed is EIF4EBP1; the disease is colorectal carcinoma.